The Edit Health Review: The Second Month Is the Real Price, and It Says So

One charge a month, and the second month is higher than the first on the two GLP-1s. Compounded tirzepatide is $209 for the first order and $309 a month after; compounded semaglutide is $109 then $209. The other four are flat: GHK-Cu cream $129, sermorelin $169, glutathione $199, NAD+ $249. There’s no membership line on top — the pricing accordion on each page reads "no insurance needed, no membership fee, cancel anytime" — and the price is stated to include the clinician visit, injection supplies and temperature-controlled two-day shipping. All figures read on August 7, 2026.

Holding the ongoing monthly rate: tirzepatide is $209 plus eleven months at $309, which is $3,608. Semaglutide is $109 plus eleven at $209, which is $2,408. Prepaying pulls both down — six months of tirzepatide at $1,575 works out at $263 a month, and six of semaglutide at $1,065 is $178 — but that money is billed once, at the start, and compounded medication isn’t refundable once it ships. The four non-GLP-1 treatments annualise straight: $1,548 for GHK-Cu, $2,028 for sermorelin, $2,388 for glutathione, $2,988 for NAD+.

The product pages say no, and they say it four times: "No insurance needed, no membership fee, cancel anytime" appears in the pricing accordion for sermorelin, NAD+, glutathione and GHK-Cu, and "No membership fee, cancel anytime" sits under the prepay options on both GLP-1 pages. The cancellation policy tells a different story in a different register — it’s written throughout about "membership billing," says "membership is billed on the cadence shown at checkout (for example, monthly, quarterly, or semi-annual)," and states that the Membership Agreement you accept before care begins controls where the two documents differ. Nothing there names a separate fee. It’s a wording mismatch between the marketing pages and the legal ones, and the legal ones are the ones you sign.

The Edit says no. "Same price at every dose" is printed directly under the prepay options on both the tirzepatide and semaglutide pages. That’s worth noticing because the usual pattern in this category is a ladder — the same drug billed higher at 7.5 mg than at 2.5 mg — and it’s the single most common reason a quoted GLP-1 price stops matching the bill after a few months.

Only in specific cases. If a clinician doesn’t approve you for treatment, you’re refunded in full and the intake costs nothing to start — there’s no card on file to begin with. Once a prescription is compounded and shipped, it’s final sale: "we cannot accept returns of prescription products for reuse or resale, and all sales are final." Visit fees are non-refundable once the visit has happened. Billing periods already begun aren’t pro-rated. If an order arrives damaged, defective or wrong, The Edit says it will coordinate a replacement with the dispensing pharmacy.

The help center is specific: "Every prescription is filled by The Pharmacy Hub, a licensed U.S. pharmacy." The shipping policy is looser about the same fact — it describes "one of our partner pharmacies (collectively, the 'The Edit Health Pharmacy Network'), which may include The Pharmacy Hub as the dispensing pharmacy." Naming a pharmacy at all puts The Edit ahead of most of this market. The two documents making different promises about it’s the kind of gap worth knowing before you assume which one governs.

It says all fifty. The help center answer reads "The Edit is available in all 50 U.S. states, through affiliated medical providers and pharmacy partners licensed in each jurisdiction," and adds that availability for your specific address and prescribed treatment is verified during the consultation. No excluded-state list is published anywhere on the site, so there’s nothing to check in advance — which cuts both ways, because it also means there’s no way to confirm your state before you start the intake.